We are live on ! Find out more
KALA icon

KALA BIO
KALA

112 hedge funds and large institutions have $248M invested in KALA BIO in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 23

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

7% more funds holding

Funds holding: 105 → 112 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.03% → 0.03% (-0%)

11% less call options, than puts

Call options by funds: $3.29M | Put options by funds: $3.7M

12% less capital invested

Capital invested by funds: $283M → $248M (-$35M)

Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
36
Reduced
23
Closed
18
Calls
$3.29M
Puts
$3.7M
Net Calls
-$409K
Net Calls Change
+$1.85M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.46M
2
Millennium Management
Millennium Management
New York
+$4.05M
3
Two Sigma Investments
Two Sigma Investments
New York
+$3.52M
4
CC
Caxton Corporation
New Jersey
+$2.78M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$2.69M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.9M
2
IC
Ikarian Capital
Texas
-$2.75M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.47M
4
WS
Wedbush Securities
California
-$1.15M
5
Goldman Sachs
Goldman Sachs
New York
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$73.7M – – –
O
2
OrbiMed
New York
$37.1M – – –
EAM
3
Eventide Asset Management
Massachusetts
$23.4M – – –
BlackRock
4
BlackRock
New York
$21.4M +$4.46M +237 +23%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.1M -$1.47M -78 -9%
CC
6
Caxton Corporation
New Jersey
$7.75M +$2.78M +148 +48%
Millennium Management
7
Millennium Management
New York
$5.61M +$4.05M +215 +185%
VC
8
Vivo Capital
California
$5.33M – – –
State Street
9
State Street
Massachusetts
$4.87M -$188K -10 -3%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$4.69M -$20.9M -1,113 -80%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$4.08M +$151K +8 +3%
Bank of America
12
Bank of America
North Carolina
$3.33M -$188K -10 -5%
Northern Trust
13
Northern Trust
Illinois
$3.26M -$56.4K -3 -2%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$3.23M – – –
Two Sigma Investments
15
Two Sigma Investments
New York
$3.17M +$3.52M +187 New
Two Sigma Advisers
16
Two Sigma Advisers
New York
$2.68M +$2.69M +143 +953%
PHP
17
Parkman Healthcare Partners
Connecticut
$1.85M -$282K -15 -12%
N
18
Nuveen
North Carolina
$1.63M +$621K +33 +52%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$1.58M +$282K +15 +19%
Brown Advisory
20
Brown Advisory
Maryland
$1.36M – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.19M -$75.3K -4 -5%
KOCAA
22
Knights of Columbus Asset Advisors
Connecticut
$1.15M +$527K +28 +70%
CSS
23
Cubist Systematic Strategies
Connecticut
$1.06M +$1.17M +62 New
PPA
24
Parametric Portfolio Associates
Washington
$1.01M – – –
Morgan Stanley
25
Morgan Stanley
New York
$946K +$433K +23 +70%
1
2 3 4 5

KALA Hedge Fund Activity: Q4 2020 in Review

112 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2020, worth a combined $248M — down 12% from $283M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KALA positions and 18 closed out — a net gain of 7 holders — while 36 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $4.46M. The largest seller was Fidelity Investments, cutting an estimated $20.9M.

  • 112 institutional investors held KALA BIO (KALA) as of Q4 2020, up from 105 in Q3 2020.
  • Funds reported $248M of KALA BIO stock for Q4 2020, down 12% quarter-over-quarter.
  • 25 funds opened new KALA BIO positions in Q4 2020 and 18 closed out, a net change of +7 holders.
  • The largest KALA BIO buyer in Q4 2020 was BlackRock, an estimated $4.46M added.
  • The largest KALA BIO seller in Q4 2020 was Fidelity Investments, an estimated $20.9M sold.

Based on aggregated 13F filings for Q4 2020.